Art

J-GLOBAL ID：200902284125505341   Reference number：08A0939201

Anti-IgE Antibody Therapy for Japanese Cedar Pollinosis: Omalizumab Update

スギ花粉症に対する抗IgE抗体療法:オマリズマブの最新情報

Author (2)： OKUBO Kimihiro (Dep. of Otorhinolaryngology, Nippon Medical School) ,  NAGAKURA Toshikazu (Yoga Allergy Clinic)
Material： Allergology International  (Allergol Int)
Volume： 57  Issue： 3  Page： 205-209 (J-STAGE)  Publication year： 2008 
JST Material Number： L6446A  ISSN： 1323-8930  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： Cryptomeria japonica ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0939201&from=J-GLOBAL&jstjournalNo=L6446A") }}

JST classification (2)： Treatment for immunologic diseases,allergic diseases.  (GD04030Y) ,  Drug therapy(=pharmacotherapy)for diseases of ear,nose,pharynx and larynx  (GQ05020H)

Reference (14)：

• PRESTA, LG. Humanization of an antibody directed against IgE. J Immunol. 1993, 151, 2623-2632
• HUMBERT, M. Add-on omalizmab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma. Allergy. 2008, 63, 592-596
• WU, AC. Cost-effectiveness of omalizumab in adults with severe asthma : results from the Asthma Policy Model. J Allergy Clin Immunol. 2007, 120, 1146-1152
• REVICKI, D. Questioning the economic evaluation of omalizumab. J Allergy Clin Immunol. 2008, 121, 1514
• MACGLASHAN, DW Jr. Down-regulation of FcεRI expression on basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol. 1997, 158, 1438-1445

Terms in the title (5)： スギ花粉症 ,  抗IgE抗体 ,  療法 ,  オマリズマブ ,  最新情報